Key Publications January 30, 2017

Should patients with cardiovascular risk factors receive intensive treatment of hypertension to <120/80 mmHg target? An antagonist view from the HOPE-3 trial (Heart Outcomes Evaluation-3).

Circulation. 2016;134:1311-1313

Lonn EM, Yusuf S